[1]
Shabbir, S. et al. 2020. COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA. Pakistan Armed Forces Medical Journal. 70, 6 (Dec. 2020), 1671–75.